Kanuma 2 mg/ml
Kanuma 2 mg/ml is a medicine authorised by Swissmedic under authorisation number 66160. The authorisation holder is Alexion Pharma GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 July 2016 and the authorisation is valid without a time limit. ATC code A16AB14 places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 66160 |
|---|---|
| Name | Kanuma 2 mg/ml |
| Full name | Kanuma 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Alexion Pharma GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A16AB14 |
| First authorisation | 21 July 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Kanuma 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung | B | 21 July 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | A16AB14 | 04.05.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Kanuma 2 mg/ml authorised in Switzerland?
Yes. Kanuma 2 mg/ml is authorised by Swissmedic under authorisation number 66160, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Kanuma 2 mg/ml have?
Kanuma 2 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Kanuma 2 mg/ml?
The authorisation holder is Alexion Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.